About Autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome
Autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome is a rare disease catalogued by Orphanet (ORPHA:363429). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to Autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome trials.
Search ClinicalTrials.gov for "Autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome" or Orphanet code ORPHA:363429 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting Autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome. Updated daily.